Topics

First large-scale clinical trials in psilocybin therapy for treatment-resistant depression launches

15:52 EST 11 Dec 2017 | CentreWatch

COMPASS Pathways, a healthcare company dedicated to accelerating patient access to evidence-based innovation in mental health, announced that it is partnering with Worldwide Clinical Trials to conduct a major program of late-stage clinical trials for psilocybin therapy for treatment-resistant depression. Depression is the leading cause of ill-health and disability worldwide, and one of the fastest growing health […]

The post First large-scale clinical trials in psilocybin therapy for treatment-resistant depression launches appeared first on CenterWatch News Online.

Original Article: First large-scale clinical trials in psilocybin therapy for treatment-resistant depression launches

NEXT ARTICLE

More From BioPortfolio on "First large-scale clinical trials in psilocybin therapy for treatment-resistant depression launches"

Quick Search

Relevant Topics

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...

Psychiatry
Psychiatry is the study of mental disorders and their diagnosis, management and prevention.  Conditions include schizophrenia, severe depression and panic disorders among others. There are pharmaceutical treatments as well as other therapies to help...